Follow The Filings

NAMS position history

The shares of Newamsterdam Pharma (NAMS) that VIKING GLOBAL INVESTORS LP reported in each quarter’s 13F.

Equity, ORDINARY SHARES

Shares held by quarter

New Add Reduce Exit

  1. 2022 Q4: 3,753,828 shares, $39M, 0.20% of portfolio, New
  2. 2023 Q1: 3,915,870 shares, $53M, 0.25% of portfolio, Add +4.3%
  3. 2023 Q2: 6,524,565 shares, $78M, 0.32% of portfolio, Add +66.6%
  4. 2023 Q3: 8,024,565 shares, $74M, 0.30% of portfolio, Add +23.0%
  5. 2023 Q4: 8,024,565 shares, $90M, 0.33% of portfolio
  6. 2024 Q1: 8,024,565 shares, $190M, 0.71% of portfolio
  7. 2024 Q2: 8,024,565 shares, $154M, 0.59% of portfolio
  8. 2024 Q3: 8,024,565 shares, $133M, 0.49% of portfolio
  9. 2024 Q4: 6,978,534 shares, $179M, 0.58% of portfolio, Reduce −13.0%
  10. 2025 Q1: 6,978,534 shares, $143M, 0.45% of portfolio
  11. 2025 Q2: 6,978,534 shares, $126M, 0.37% of portfolio
  12. 2025 Q3: 6,475,534 shares, $184M, 0.48% of portfolio, Reduce −7.2%
  13. 2025 Q4: 4,203,567 shares, $147M, 0.39% of portfolio, Reduce −35.1%
  14. 2026 Q1: 4,203,567 shares, $135M, 0.38% of portfolio
  15. 2026 Q2: 4,203,567 shares, $142M, 0.41% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders